IV Antibiotic Duration and Oral Step-Down in Acute Infective Endocarditis
For acute infective endocarditis, administer IV antibiotics for a minimum of 10 days, then transition to oral therapy in clinically stable patients, completing a total treatment duration of 4 weeks for native valve endocarditis or 6 weeks for prosthetic valve endocarditis.
Total Treatment Duration by Valve Type
The duration depends on whether you're treating native valve endocarditis (NVE) or prosthetic valve endocarditis (PVE):
- Native valve endocarditis: 4 weeks total treatment 1, 2
- Prosthetic valve endocarditis: 6 weeks total treatment 1, 2
- Enterococcal endocarditis: 4-6 weeks for NVE (depending on symptom duration before treatment initiation), 6 weeks for PVE 1
Criteria for Oral Step-Down Therapy
After at least 10 days of effective IV antibiotics, you can transition to oral therapy if the patient meets ALL of the following criteria 3, 4:
- Afebrile (no fever)
- Hemodynamically stable (no heart failure requiring active management)
- Negative blood cultures (bacteremia cleared)
- No uncontrolled infection on imaging (no expanding abscess or new complications)
- Appropriate oral agent available with high bioavailability and pathogen-directed activity
The landmark POET trial demonstrated that oral step-down therapy after at least 10 days of IV treatment was non-inferior to continued IV therapy for left-sided endocarditis caused by streptococci, Enterococcus faecalis, Staphylococcus aureus, or coagulase-negative staphylococci 3. This approach resulted in similar rates of death, relapse, embolic events, and unplanned cardiac surgery, while substantially reducing hospital length of stay and line-related complications 5, 4.
Pathogen-Specific Considerations
Streptococcal IE
Staphylococcal IE
- Native valve: 4 weeks total (can use 2-week regimen only for uncomplicated right-sided MSSA IE) 2
- Prosthetic valve: 6 weeks total, with gentamicin for first 2 weeks and rifampin throughout 2, 6
- Oral step-down feasible after 10 days in stable patients 3
Enterococcal IE
- 4-6 weeks for NVE, 6 weeks for PVE 1
- Requires synergistic combination therapy throughout treatment course 2
- Ampicillin-ceftriaxone: 6 weeks regardless of symptom duration 1
- Ampicillin-gentamicin: 4-6 weeks depending on symptom duration 1
HACEK Organisms
Important Caveats and Pitfalls
Avoid oral step-down in these situations:
- Active heart failure requiring ongoing management
- Persistent bacteremia (positive blood cultures after initial treatment)
- Perivalvular abscess or other uncontrolled local complications
- Multidrug-resistant organisms without suitable oral options 5
- People who inject drugs (limited data) 5
Common mistake: Starting the clock for total treatment duration from diagnosis rather than from the start of effective antibiotic therapy. The duration should be counted from when appropriate antibiotics were initiated 1, 2.
Volume overload consideration: For enterococcal endocarditis requiring ampicillin-ceftriaxone, consider push administration rather than continuous infusion to reduce fluid volume in patients susceptible to heart failure 7. This is particularly relevant given the high salt and volume load associated with 6 weeks of IV therapy.
Empirical Therapy Before Pathogen Identification
While awaiting blood culture results in acute, severely ill patients 2:
Community-acquired NVE or late PVE (≥12 months post-surgery):
- Ampicillin 12g/day IV + (flu)cloxacillin/oxacillin 12g/day IV + gentamicin 3mg/kg/day
- For penicillin allergy: Vancomycin + gentamicin
Early PVE (<12 months) or healthcare-associated IE:
- Vancomycin 30mg/kg/day IV + gentamicin 3mg/kg/day IV
- Add rifampin 900-1200mg/day after 3-5 days for PVE
Adjust therapy once pathogen is identified (usually within 48 hours) 2.